Last reviewed · How we verify

NCT05131542

Assessment of Hypotonia in Children With Down Syndrome

Completed Last updated 21 January 2022
What this trial tests

trial in Muscle Hypotonia in 50 participants. Completed in 15 January 2022.

Timeline
1 April 2019
Primary endpoint
31 December 2021
15 January 2022

Quick facts

Lead sponsorUniversidad de Murcia
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date1 April 2019
Primary completion31 December 2021
Estimated completion15 January 2022
Sites1 location across Spain

Conditions studied

Sponsor

Universidad de Murcia — full company profile →

Who can join

Adults 7 Months to 8, any sex, with Muscle Hypotonia or Down Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hypotonia is a common trait in infants with Down syndrome, resulting in pathologies and delays in gaining basic motor skills. There are no screenings available to aid in early diagnosis, therefore, the purpose of this study is to develop a way to test for hypotonia in children with Down syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Muscle Hypotonia

Currently open trials in the same condition.

Other Universidad de Murcia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05131542.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing